re: production cost Bioshares (6 May) in its article on SIE indicates that the Hep B is manufactured thru a cloning process and indicates
a "modest capital expenditure" Sales so far have been modest $750000. I am impressed by this Company so may have a blinkered view BUT?
- Forums
- ASX - By Stock
- SIE
- no approval yet in china ??
no approval yet in china ??, page-8
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)